Table 3.
Risk of cognitive decline according to cognitive screening at baseline
Cognitive screening at baseline | Cognitive decline at follow-up | |
---|---|---|
Unadjusted model | Adjusted model | |
(HR, 95% CI) | (HR, 95% CI) | |
CDT stand-alone | ||
CDT ≥ 6.55 | 1 | 1 |
CDT < 6.55 | 3.100 (1.704–5.637) # | 2.022 (1.025–3.989) * |
MoCA-B stand-alone | ||
MoCA-B ≥ 24 | 1 | 1 |
MoCA-B < 24 | 1.937 (0.939–3.995) | 0.687 (0.293–1.610) |
CS | ||
CS = 2 (MoCA-B ≥ 24 and CDT ≥ 6.55) | 1 | 1 |
CS = 1 (MoCA-B < 24 or CDT < 6.55) | 4.188 (1.690–10.380) * | 1.988 (0.646–6.119) |
CS = 0 (MoCA-B < 24 and CDT < 6.55) | 1.732 (0.676–4.437) | 1.063 (0.364–3.103) |
Model 1: unadjusted; Model 2: adjusted for age, education, CIRS total score, NIHSS at admission, Pasquier scale score
CDT clock-drawing test, MoCA-B Montreal Cognitive Assessment-Basic, CS Combined score
*Significant with p < 0.05
#Significant with p < 0.001